To investigate the predictive power of circulating levels of FSCN1 in the tumor progression, we evaluated any association between pre-surgery FSCN1 concentrations and clinical characteristics of ACC patients (see Table 1). The gene discussed is FSCN1; the disease is adrenal cortex carcinoma.